Lv42
490 积分 2024-11-20 加入
Preclinical Study of a Biparatopic METxMET Antibody–Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC
14天前
已完结
Elranatamab: First Approval
3个月前
已完结
A novel method for determining antibody-dependent cellular phagocytosis
4个月前
已完结
One-Pot Assembly of Dual-Site-Specific Antibody–Drug Conjugates via Glycan Remodeling and Affinity-Directed Traceless Conjugation
4个月前
已完结
皖公网安备34019202002308
